Culture & Society

GLP-1 use is way up in a key demographic — rates are 24x higher than in 2018

Despite many other benefits that have emerged, people are mainly on it to shed pounds — including one demographic in particular, whose use of the drug has skyrocketed from .8% in 2018 to 1.9% in 2025 — a 24-fold increase.

Representative image for this curated culture & society brief.

Expanded Context

Brimstone Report is tracking this as a curated culture & society brief. The source report from NY Post says: Despite many other benefits that have emerged, people are mainly on it to shed pounds — including one demographic in particular, whose use of the drug has skyrocketed from .8% in 2018 to 1.9% in 2025 — a 24-fold increase.

This page is not original reporting. It gives readers the Brimstone view of the story: what is known from the attributed source, why the topic matters, and where to continue reading the original report.

At publication, this brief is anchored to a single attributed source. Readers should treat early details as provisional until additional reporting, official statements, or documents appear.

Why It Matters

Culture stories shape public debate around media, technology, education, institutions, and social norms. The useful angle is what changed and why people are paying attention.

Key Facts

  • Primary source: NY Post
  • Published: Oct 3, 2026, 2:47 PM UTC
  • Coverage area: Culture & Society
  • Brimstone role: curated summary, explanation, and source attribution
  • Topic signals: developing story metadata

Timeline

  1. Source published: Oct 3, 2026, 2:47 PM UTC
  2. Brimstone indexed: Added to the curated Brimstone feed and linked to related coverage.
  3. Next update to watch: Additional sourcing, official confirmation, court or agency records, or follow-up reporting.

Source Attribution

This Brimstone page summarizes and contextualizes a third-party report. Continue to the original publisher for full reporting, documents, quotes, and updates.

Read Original Source

Related Stories